Evidence-based management of HCC: Systematic review and meta-analysis of randomized controlled trials (2002-2020)

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality with a rapidly changing landscape of treatments. In the past 20 years, numerous randomized controlled trials (RCT) have aimed at improving outcomes across disease stages. We aimed at analyzing the current evidence and identifying potential factors influencing response to therapies.

Source: Gastroenterology - June 11, 2021 Category: Gastroenterology Authors: Philipp K. Haber, Marc Puigveh í, Florian Castet, Vennis Lourdusamy, Robert Montal, Parissa Tabrizian, Michael Buckstein, Edward Kim, Augusto Villanueva, Myron Schwartz, Josep M. Llovet Source Type: research